Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Role of the copper transporter, CTR1, in platinum-induced ototoxicity.
More SS, Akil O, Ianculescu AG, Geier EG, Lustig LR, Giacomini KM. More SS, et al. Among authors: ianculescu ag. J Neurosci. 2010 Jul 14;30(28):9500-9. doi: 10.1523/JNEUROSCI.1544-10.2010. J Neurosci. 2010. PMID: 20631178 Free PMC article.
3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology?
Ianculescu AG, Scanlan TS. Ianculescu AG, et al. Mol Biosyst. 2010 Aug;6(8):1338-44. doi: 10.1039/b926583j. Epub 2010 Mar 4. Mol Biosyst. 2010. PMID: 20623079 Review.
3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulator.
Gompf HS, Greenberg JH, Aston-Jones G, Ianculescu AG, Scanlan TS, Dratman MB. Gompf HS, et al. Among authors: ianculescu ag. Brain Res. 2010 Sep 10;1351:130-40. doi: 10.1016/j.brainres.2010.06.067. Epub 2010 Jul 23. Brain Res. 2010. PMID: 20615397 Free PMC article.
Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions.
Ahlin G, Chen L, Lazorova L, Chen Y, Ianculescu AG, Davis RL, Giacomini KM, Artursson P. Ahlin G, et al. Among authors: ianculescu ag. Pharmacogenomics J. 2011 Dec;11(6):400-11. doi: 10.1038/tpj.2010.54. Epub 2010 Jun 22. Pharmacogenomics J. 2011. PMID: 20567254
Transport of thyroid hormones is selectively inhibited by 3-iodothyronamine.
Ianculescu AG, Friesema EC, Visser TJ, Giacomini KM, Scanlan TS. Ianculescu AG, et al. Mol Biosyst. 2010 Aug;6(8):1403-10. doi: 10.1039/b926588k. Epub 2010 Mar 31. Mol Biosyst. 2010. PMID: 20358049 Free PMC article.
Evidence for a homodimeric structure of human monocarboxylate transporter 8.
Visser WE, Philp NJ, van Dijk TB, Klootwijk W, Friesema EC, Jansen J, Beesley PW, Ianculescu AG, Visser TJ. Visser WE, et al. Among authors: ianculescu ag. Endocrinology. 2009 Nov;150(11):5163-70. doi: 10.1210/en.2009-0699. Epub 2009 Sep 24. Endocrinology. 2009. PMID: 19797118 Free PMC article.
Identification and characterization of 3-iodothyronamine intracellular transport.
Ianculescu AG, Giacomini KM, Scanlan TS. Ianculescu AG, et al. Endocrinology. 2009 Apr;150(4):1991-9. doi: 10.1210/en.2008-1339. Epub 2008 Dec 12. Endocrinology. 2009. PMID: 19074582 Free PMC article.
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.
Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM. Shu Y, et al. Among authors: ianculescu ag. J Clin Invest. 2007 May;117(5):1422-31. doi: 10.1172/JCI30558. J Clin Invest. 2007. PMID: 17476361 Free PMC article.
A conserved RING finger protein required for histone H2B monoubiquitination and cell size control.
Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C, Madhani HD. Hwang WW, et al. Among authors: ianculescu ag. Mol Cell. 2003 Jan;11(1):261-6. doi: 10.1016/s1097-2765(02)00826-2. Mol Cell. 2003. PMID: 12535538 Free article.
A mathematical model of the impact of infused targeted cytotoxic agents on brain tumours: implications for detection, design and delivery.
Wein LM, Wu JT, Ianculescu AG, Puri RK. Wein LM, et al. Among authors: ianculescu ag. Cell Prolif. 2002 Dec;35(6):343-61. doi: 10.1046/j.1365-2184.2002.00246.x. Cell Prolif. 2002. PMID: 12427253 Free PMC article.